3 active warrant series covering 5,793,750 shares (~6.6% potential dilution); nearest expiry 2027-11-07.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.12 | Nov 7, 2027 404d | 2.9M | OTM | 3.3% | C$348K | Auto |
| finder | $0.12 | Nov 7, 2027 404d | 206K | OTM | 0.2% | C$24K | Auto |
| warrant | $0.12 | Nov 7, 2027 404d | 2.7M | OTM | 3.1% | C$309K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 5,315,000 shares (~6.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Sep 29, 2027 365d | 1.3M | OTM | 1.5% | C$89K | Auto |
| option | $0.06 | May 17, 2029 961d | 2.1M | ITM | 2.4% | C$125K | Auto |
| option | $0.08 | Oct 1, 2030 1463d | 1.9M | OTM | 2.2% | C$156K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
87,466,826 shares outstanding, plus 5,793,750 from warrants and 5,315,000 from options — a fully diluted 98,575,576 shares, or ~12.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 5,793,750 shares (~6.6% potential dilution); nearest expiry 2027-11-07.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.12 | Nov 7, 2027 404d | 2.9M | OTM | 3.3% | C$348K | Auto |
| finder | $0.12 | Nov 7, 2027 404d | 206K | OTM | 0.2% | C$24K | Auto |
| warrant | $0.12 | Nov 7, 2027 404d | 2.7M | OTM | 3.1% | C$309K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 5,315,000 shares (~6.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Sep 29, 2027 365d | 1.3M | OTM | 1.5% | C$89K | Auto |
| option | $0.06 | May 17, 2029 961d | 2.1M | ITM | 2.4% | C$125K | Auto |
| option | $0.08 | Oct 1, 2030 1463d | 1.9M | OTM | 2.2% | C$156K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
87,466,826 shares outstanding, plus 5,793,750 from warrants and 5,315,000 from options — a fully diluted 98,575,576 shares, or ~12.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
